Acer Therapeutics Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Acer Therapeutics Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2023.
  • Acer Therapeutics Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 8, 2023 was 24.5M shares, a 49.4% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2023 24.5M +8.09M +49.4% Nov 8, 2023 10-Q 2023-11-20
Q2 2023 24.5M +8.52M +53.4% Aug 1, 2023 10-Q 2023-08-14
Q1 2023 23.4M +8.11M +53% Mar 24, 2023 10-K 2023-03-27
Q3 2022 16.4M +2.06M +14.4% Nov 1, 2022 10-Q 2022-11-14
Q2 2022 15.9M +1.63M +11.4% Aug 1, 2022 10-Q/A 2022-11-14
Q1 2022 15.3M +1M +6.99% May 1, 2022 10-Q 2022-05-16
Q4 2021 14.3M Jan 15, 2022 10-K 2022-03-02
Q3 2021 14.3M +2.03M +16.5% Nov 1, 2021 10-Q 2021-11-19
Q2 2021 14.3M +2.4M +20.1% Aug 1, 2021 10-Q/A 2021-11-19
Q1 2021 14.3M +4.22M +41.8% May 1, 2021 10-Q/A 2021-11-19
Q3 2020 12.3M +2.19M +21.7% Nov 1, 2020 10-Q 2020-11-10
Q2 2020 11.9M +1.82M +18% Aug 6, 2020 10-Q 2020-08-13
Q1 2020 10.1M +7.81K +0.08% Mar 1, 2020 10-K 2020-03-18
Q3 2019 10.1M +42.2K +0.42% Nov 1, 2019 10-Q 2019-11-13
Q2 2019 10.1M +42.2K +0.42% Aug 1, 2019 10-Q 2019-08-13
Q1 2019 10.1M +2.59M +34.5% Mar 1, 2019 10-K 2019-03-07
Q3 2018 10.1M +3.6M +55.8% Oct 31, 2018 10-Q 2018-11-09
Q2 2018 10.1M +2.4M +31.3% Aug 10, 2018 10-Q 2018-08-13
Q1 2018 7.5M -160K -2.09% Mar 1, 2018 10-K 2018-03-07
Q3 2017 6.45M -690K -9.67% Nov 1, 2017 10-Q 2017-11-13
Q2 2017 7.66M +608K +8.63% Aug 1, 2017 10-Q 2017-08-14
Q1 2017 7.66M +670K +9.59% Mar 10, 2017 10-K 2017-03-28
Q3 2016 7.14M +277K +4.03% Nov 1, 2016 10-Q 2016-11-14
Q2 2016 7.05M -46.3M -86.8% Aug 1, 2016 10-Q 2016-08-11
Q1 2016 6.99M -46.4M -86.9% Mar 10, 2016 10-K 2016-03-15
Q3 2015 6.86M -21.3M -75.6% Nov 1, 2015 10-Q 2015-11-10
Q2 2015 53.4M +25.6M +92.4% Aug 1, 2015 10-Q 2015-08-12
Q1 2015 53.4M +25.7M +92.9% May 1, 2015 10-Q 2015-05-12
Q3 2014 28.2M +5.45M +24% Nov 1, 2014 10-Q 2014-11-06
Q2 2014 27.8M +7.64M +38% Aug 1, 2014 10-Q 2014-08-14
Q1 2014 27.7M +19.7M +246% May 1, 2014 10-Q 2014-05-14
Q3 2013 22.7M -319K -1.38% Nov 5, 2013 10-Q 2013-11-07
Q2 2013 20.1M -2.93M -12.7% Aug 13, 2013 10-Q 2013-08-14
Q1 2013 7.99M -15.1M -65.3% Mar 15, 2013 10-K 2013-03-29
Q3 2012 23M 0 0% Nov 2, 2012 10-Q 2012-11-14
Q2 2012 23M 0 0% Jul 31, 2012 10-Q 2012-08-13
Q1 2012 23M Apr 30, 2012 10-Q 2012-05-11
Q3 2011 23M Oct 31, 2011 10-Q 2011-11-04
Q2 2011 23M Jul 31, 2011 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.